loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Netarsudil

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Netarsudil

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 269,613Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alcon Completes Acquisition of Aerie Pharmaceuticals
    Alcon Completes Acquisition of Aerie Pharmaceuticals

    22 Nov 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221121005923/en

    BUSINESSWIRE
    22 Nov 2022
    Share Share
    Aerie Pharmaceuticals Announces New Employee Inducement Grant
    Aerie Pharmaceuticals Announces New Employee Inducement Grant

    15 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220815005097/en

    BUSINESSWIRE
    15 Aug 2022
    Share Share
    Aerie Announces 1st Participant Dosed in COMET-3 Study of AR-15512
    Aerie Announces 1st Participant Dosed in COMET-3 Study of AR-15512

    01 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220801005762/en

    BUSINESSWIRE
    01 Aug 2022
    Share Share
    Aerie Concludes Exclusive License Agreement With Santen for Rhopressa, Rocklatan
    Aerie Concludes Exclusive License Agreement With Santen for Rhopressa, Rocklatan

    07 Dec 2021

    // PRESS RELEASE

    https://investors.aeriepharma.com/news-releases/news-release-details/aerie-concludes-exclusive-license-agreement-santen-rhopressar

    PRESS RELEASE
    07 Dec 2021
    Share Share
    Aerie Announces Positive Phase 3 Topline Results for Netarsudil in Japan
    Aerie Announces Positive Phase 3 Topline Results for Netarsudil in Japan

    12 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211012005106/en

    BUSINESSWIRE
    12 Oct 2021
    Share Share
    Meeting highlights from the Committee for Medicinal Products for Human Use
    Meeting highlights from the Committee for Medicinal Products for Human Use

    13 Nov 2020

    // EMA

    https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-9-12-november-2020

    EMA
    13 Nov 2020
    Share Share